Translocations involving a breakpoint cluster region of the MLL gene at chromosome band 11q23 are the most common molecular abnormalities in acute leukemias of infants and acute leukemias related to chemotherapy with DNA topoisomerase II inhibitors. Molecular cloning of MLL genomic breakpoints by PCR has previously been difficult because MLL has many translocation partners and several breakpoints involve unknown partner genes. We review a new approach to MLL genomic breakpoint cloning called panhandle PCR. By adding an oligonucleotide sequence to the unknown 3′ partner gene that is complementary to a known 5′ MLL sequence, we have been able to generate a genomic template with an intrastrand loop for PCR schematically shaped like a pan with a handle. The intrastrand loop contains the translocation breakpoint and unknown partner DNA, while the handle contains the known 5′ sequence from MLL and a complement to that sequence. Primers both derived from MLL are used to amplify the breakpoint by panhandle PCR. Panhandle PCR offers the advantage of having specificity for the strand of interest at both primer annealing sites without requiring specific primers for the many partner genes of MLL. Panhandle PCR is a straightforward method that represents a technical advance in MLL genomic breakpoint cloning.
Introduction
Translocations of an 8.3 kb breakpoint cluster region (bcr) located between exons 5 and 11 of the MLL gene at chromosome band 11q23 are present in the majority of de novo leukemias of infants and in the majority of leukemias related to chemotherapy with DNA topoisomerase II inhibitors. [1] [2] [3] [4] [5] [6] [7] MLL genomic breakpoint cloning may advance our understanding of whether exogenous damage to the MLL gene by anticancer drugs, environmental toxins or DNA topoisomerase II inhibitors in foods is the common factor in leukemia pathogenesis in treatment-related and de novo cases. [8] [9] [10] [11] The potential role of DNA topoisomerase II in the translocation mechanism and the sufficiency of specific translocations for full leukemogenesis are different biologic questions that require isolation of the breakpoints. 12 a poor prognosis in infant ALL. 3, 4, [14] [15] [16] [17] MLL genomic breakpoint cloning also will determine whether rearrangements of the MLL gene with different translocation partners affect prognosis further.
MLL genomic breakpoint cloning by PCR previously has been difficult because many of the translocations are composed of known 5′ sequences from MLL, but 3′ sequences from unknown partner genes. The MLL gene has an estimated 30 different partner genes. 2 Although 11 partner genes of MLL already have been cloned, specific sequence information is often limited to cDNAs. [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] Sequences of two-thirds of the partner genes have not yet been determined and, thus, are not available for PCR-based translocation breakpoint cloning. In approximately one-third of cases with molecular MLL gene rearrangement at the level of the Southern blot, karyotype analysis does not detect the translocation or give information about potential translocation partners. 7 Other rearrangements result from tandem duplication of several exons of the MLL gene. The karyotypes in these cases do not show abnormalities at chromosome band 11q23. 29, 30 Thus, there is a need for new technology to clone MLL genomic breakpoints directly from genomic DNA.
We have used panhandle PCR, which amplifies genomic DNA with known 5′ and unknown 3′ sequences from a template schematically shaped like a pan with a handle, [31] [32] [33] as a new approach to MLL genomic breakpoint cloning. 34, 35 The adaptation of the method should amplify the breakpoints within the bcr with unknown 3′ sequences. 34, 35 General description of panhandle PCR methodology
Identification of MLL genomic breakpoints within the bcr
We isolate high molecular weight genomic DNAs for Southern blot analysis and panhandle PCR by ultracentrifugation on 4M GITC-5.7M CsCl gradients. 36 Since leukemia in infants typically presents with high WBC and large tumor burden, material for molecular analysis usually is plentiful. Before performing panhandle PCR, genomic DNA from the leukemia of interest is examined for rearrangement of the 8.3 kb BamHI fragment that encompasses the MLL genomic bcr by Southern blot analysis. 7 The sizes of the rearrangements on the Southern blot are approximate sizes of the target sequences for PCR. 34, 35 In treatment-related cases, material for molecular analysis often is more limited. Additional breakpoint mapping by Southern blot analysis, which consumes additional DNA, is unnecessary either for design of primers or design of panhandle PCR conditions.
Formation of the template for panhandle PCR
The method summarized in Figure 1 amplifies the breakpoint on the der(11) chromosome. The first step in making the template for panhandle PCR is restriction enzyme cleavage with an enzyme that creates a 5′ overhang. 31, 33 For leukemias with MLL gene translocations, BamHI is most appropriate because virtually all MLL genomic breakpoints are within the same 8.3 kb BamHI restriction fragment. 34, 35 BamHI digestion produces a restriction fragment with known MLL sequence at the 5′ side of the translocation breakpoint and unknown 3′ sequence from the partner DNA. 34, 35 The DNA is treated with calf intestinal alkaline phosphatase to prevent religation in Step 2.
31-33
The purpose of Steps 2 and 3 is to form the handle. [31] [32] [33] Formation of the handle attaches known MLL DNA to 3′ of the unknown partner DNA and brings the translocation breakpoint and unknown partner DNA within an intrastrand loop or pan. 34, 35 Step 2 involves ligation of a single-stranded 5′ phosphorylated oligonucleotide to the 3′ ends of the digested DNA. The 4-base 5′ end of the oligonucleotide is complementary to the 5′ overhang of BamHI-digested DNA; its 3′ end is complementary to nucleotides in MLL exon 5, which is in the 5′ bcr. 34, 35 The sense strand (top strand in Step 2, Figure 1 ) becomes the template strand in Step 3.
Formation of the handle is completed in Step 3 by intrastrand annealing of the ligated oligonucleotide to the complementary sequence in MLL and polymerase extension of the recessed 3′ end. [33] [34] [35] An aliquot of the BamHI-digested, ligated DNA is added to a reaction mixture of DNA polymerase, dNTPs, and PCR reaction buffer. [33] [34] [35] We preheat reaction mixtures to 80°C before addition of the DNA to prevent nonspecific annealing and polymerization. After addition of the DNA, we heat reaction mixtures at 94°C × 1 min to make the template single-stranded by heat denaturation. Intrastrand annealing of the ligated oligonucleotide to its complementary sequence in MLL and template-directed polymerase extension of the recessed 3′ end occur during a 2 min ramp to 72°C and incubation at 72°C × 30 s to complete formation of the handle. 33 The intrastrand loop contains the translocation breakpoint and unknown partner DNA, while the handle contains known 5′ sequence from MLL and a complement to that sequence. 34, 35 PCR amplification of MLL genomic breakpoints from template DNA shaped like a pan with a handle
With MLL sequences at both ends of the template, we use MLL primers all sense with respect to exon 5 to amplify the breakpoint junction. 34, 35 The positions and orientations of the primers with respect to the ligated oligonucleotide are shown in Figure 1 , Step 1.
Step 4 is to add MLL primers and thermal cycle. MLL primer 1 is homologous to exon 5 upstream to the MLL sequence that is complementary to the ligated oligonucleotide, allowing primer 1 to anneal to the DNA previously attached to the 3′ end of the ligated oligonucleotide by template-directed polymerase extension in Step 3. MLL primer 2 is homologous to exon 5 between the MLL sequence that is complementary to the ligated oligonucleotide, and the translocation breakpoint. A nested PCR reaction with primers 3 and 4, also from MLL exon 5, enhances the yield of products from panhandle PCR 34, 35 ( Figure 1 ). Step 2. Ligation of single-stranded 5′ phosphorylated oligonucleotide to the 3′ ends
The sequence of the 5′ phosphorylated oligonucleotide for amplification of the translocation breakpoint on the der(11) chromosome is 5′-GAT CGA AGC TGG AGT GGT GGC CTG TTT GGA TTC AGG-3′. Step 1 in building the template is digestion of genomic DNA with BamHI to produce a restriction fragment with a 5′ overhang. The DNA has known MLL sequence at the 5′ side of the translocation breakpoint flanked by unknown 3′ sequence from the partner DNA. Formation of the handle attaches known MLL DNA to 3′ of the unknown partner sequence and brings the breakpoint junction within an intrastrand loop or pan. First, a single-stranded 5′ phosphorylated oligonucleotide that is complementary to a 5′ sequence in MLL exon 5, is ligated to the unknown 3′ end (Step 2). The sense strand (top strand in Step 2) becomes the template strand. Formation of the handle is completed in Step 3 by intrastrand annealing of the ligated oligonucleotide to the complementary sequence in MLL and polymerase extension of the recessed 3′ end. With MLL sequences at both ends of the template, primers 1 and 2 from MLL exon 5 are used to amplify the breakpoint junction (Step 4). Nested PCR with primers 3 and 4 enhances yield (Step 5).
Step 3. Panhandle formation: addition of DNA to Taq/dNTP mixture, denaturation, intrastrand annealing and polymerase extension Step 4 prevents priming at low stringency and the generation of nonspecific products, and thus provides a hot-start for the initial PCR. 37 Step 4. Addition of MLL primers 1 and 2 and thermal cycling
(1) The sequence of MLL primer 1 is 5′-TCC TCC ACG AAA GCC CGT CGA G-3′ and the sequence of MLL primer 2 is 5′-TCA AGC AGG TCT CCC AGC CAG CAC-3′. With the reaction mixtures at 80°C, add 12.5 pmoles each primer in 2.5 l volumes to below the mineral oil layer. This will bring concentrations in 50 l final reaction volumes to 350 M each dNTP and 1 × PCR reaction buffer. In the original method, primer 2 had a nucleotide added to its 5′ end that was not complementary to the template. This was a precaution to prevent short-circuiting of the reaction when using Taq DNA polymerase alone during PCR, since short-circuiting could occur by the annealing of the 3′ end of one strand of a short nonspecific PCR product to the template DNA. The necessity of this precaution was not tested and the success of the method when using long-range PCR reagents that include a DNA polymerase with 3′ exonuclease activity suggests that the precaution is unnecessary. (2) If Southern blot information is available, the information can be used to determine the duration of the elongation segment in the PCR reaction (ෂ1 min/kb). 34, 35 To amplify products 8.3 kb and 7 kb in size, we used the following conditions: initial denaturation at 94°C × 1 min; 10 cycles at 94°C × 10 s, 68°C × 7 min; 20 cycles at 94°C × 10 s, 68°C × 7 min (increment 20 s/cycle); final elongation at 68°C × 7 min. 34 Shorter products can be amplified using shorter elongation times. 35 Step 5. Perform nested PCR using primers 3 and 4
(1) Figure 1 shows positions of the nested primers 3 and 4.
The sequences are 5′-A GCT GGA TCC GGA AAA GAG TGA AGA AGG GAA TGT CTC GG-3′ and 5′-A GCT GGA TCC GTG GTC ATC CCG CCT CAG CCA C-3′, respectively. Underlined sequences are BamHI sites. To 25 l of 2 × PCR mix (c.f.
Step 3), add 19 l of dH 2 O, 2.5 l each (12.5 pmoles) of primers 3 and 4, and a 1 l aliquot of the initial PCR reaction products. Layer with mineral oil. Use the same conditions for nested PCR as for the initial panhandle PCR reaction. Visualize 3 l of the nested panhandle PCR reaction products on an ethidium-stained minigel. Detection of a product of the same size as the BamHI fragment on the genomic Southern blot will be the first indication that the amplified products at the end of Step 5 contain the target sequence.
Subcloning and sequencing of the products of panhandle PCR Primers 3 and 4 for the nested panhandle PCR reaction contain BamHI restriction sites for subcloning. The products of panhandle PCR are agarose gel-isolated and subcloned for sequencing of the translocation breakpoint and the unknown partner DNA.
To validate the results, we routinely have designed primers encompassing the translocation breakpoint from sequences of the subcloned products of panhandle PCR, amplified fresh aliquots of genomic DNA from the leukemia, and performed direct genomic sequencing.
Guidelines for troubleshooting
One problem that may be encountered is the generation of nonspecific products. The hot-start at 80°C at the first PCR step prevents nonspecific priming and the generation of such products. 37 However, if multiple bands are seen following the nested PCR amplification, raising the annealing temperature by 1°C or 2°C in the nested PCR reaction may eliminate the shorter products. Alternatively, reducing the amount of DNA polymerase also may be helpful if this problem is encountered.
Discussion
Panhandle PCR was developed to clone genomic DNA with known 5′ sequence flanked by unknown 3′ sequence. Panhandle PCR previously amplified target sequences 2-4.4 kb in size from human ␤ globin and cystic fibrosis transmembrane conductance regulator (CFTR) test genes. 31, 32 The MLL bcr lies within an 8.3 kb region between exons 5 and 11, a length suitable for PCR analysis. The adaptation of panhandle PCR for MLL genomic breakpoint cloning ligates a phosphorylated oligonucleotide of known sequence complementary to a region in MLL exon 5, to 3′ sequence from the unknown partner gene. We have already used the method to clone three MLL genomic breakpoints and have amplified target sequences 2.5 kb to 8.3 kb in size. 34, 35 Successful application of the method in a case of infant ALL and in two treatmentrelated leukemias identified the MLL genomic breakpoints and previously uncharacterized intronic sequences in the partner genes. In two of the three cases, the karyotype did not reveal the translocation partner. 34, 35 Panhandle PCR offers advantages over other strategies for genomic translocation breakpoint cloning. The method is considerably less labor-intensive than conventional genomic cloning using phage, the method by which several MLL genomic breakpoints were isolated early on. [38] [39] [40] [41] Unlike onesided anchored PCR, panhandle PCR has specificity for the strand of interest at two primer annealing sites. 42 Unlike longdistance PCR, 43, 44 panhandle PCR does not require specific primers for the many partner genes of MLL. Inverse PCR has also been used to amplify a carcinogen-induced thymidine kinase gene rearrangement. 45 The approach included restriction enzyme cleavage on each side of the rearrangement, circularization of the restriction fragment with T4 DNA ligase, and PCR amplification with outward primers both derived from the known side of the rearrangement. 45 However, successful amplifications were limited to template sizes Ͻ1 kb. 45 We believe that panhandle PCR is a technical advance towards understanding the molecular pathogenesis of leukemias with MLL gene translocations. Although panhandle PCR contains several steps including multiple glass-bead extractions, the initial success demonstrates that panhandle PCR is a straightforward method to clone MLL genomic breakpoints. 34, 35 The maximum length of the target sequence that can be amplified by this method remains to be determined, but the same phosphorylated oligonucleotide and PCR primers from MLL exon 5 should be suitable for amplifying additional MLL genomic breakpoints contained on BamHI restriction fragments up to at least 8.3 kb. 34, 35 The method is practical in cases where genomic DNAs are limited. Panhandle PCR is a definitive PCR approach for identifying additional new partner genes of MLL and amplifying other translocation breakpoints where the partner gene is undetermined.
